GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Debt-to-Equity

MDBIF (TrivarX) Debt-to-Equity : 0.01 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Debt-to-Equity?

TrivarX's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.04 Mil. TrivarX's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. TrivarX's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $5.63 Mil. TrivarX's debt to equity for the quarter that ended in Dec. 2023 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for TrivarX's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of TrivarX was 1.52. The lowest was 0.00. And the median was 0.01.

MDBIF's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.46
* Ranked among companies with meaningful Debt-to-Equity only.

TrivarX Debt-to-Equity Historical Data

The historical data trend for TrivarX's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Debt-to-Equity Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - 0.01 0.02 -

TrivarX Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - 0.02 0.01 -

Competitive Comparison of TrivarX's Debt-to-Equity

For the Health Information Services subindustry, TrivarX's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where TrivarX's Debt-to-Equity falls into.



TrivarX Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

TrivarX's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

TrivarX's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX  (OTCPK:MDBIF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


TrivarX Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of TrivarX's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio Limited Quarterly ASX Update and Cashflows

By Marketwired Marketwired 10-30-2018

Medibio Receives TGA Approval

By Marketwired Marketwired 06-19-2018

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Provides Market Update

By Marketwired Marketwired 09-10-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018

Medibio Provides Updated Company Presentation

By Marketwired Marketwired 10-05-2018

Receipt of $3,146,835 R&D Tax Incentive Refund

By Marketwired Marketwired 10-15-2018

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018